The Monkeypox vaccine has just been given the green light by the Federal Drug Administration (FDA) to be administered via intradermal injection. This method will allow healthcare professionals to get ...

The Monkeypox vaccine has just been given the green light by the Federal Drug Administration (FDA) to be administered via intradermal injection. This method will allow healthcare professionals to get ...

The U.S. is now allowing fractional doses of the Jynneos monkeypox vaccine to be administered via an injection that delivers the dose between, rather than under, layers of skin — an effort that will ...

Under the EUA, Jynneos can be administered either intradermally for individuals aged ≥18 years or subcutaneously for individuals aged The Food and Drug Administration (FDA) has granted emergency use ...

People who are at high risk for monkeypox can now get vaccinated for the virus via intradermal injection after the U.S. Food and Drug Administration authorized the technique. The FDA issued an ...

The new intradermal technique requires just a fraction of a vaccine per shot. Some states and jurisdictions are hitting early bumps in their rollout of the U.S. government's new approach to expand ...

The approach, which would require a new emergency authorization, would involve injecting one-fifth of the current dose into the skin instead of a full dose into underlying fat. By Sharon LaFraniere ...

Intradermal vaccination can save supplies and protect more people. Amid a newly announced monkeypox national public emergency and shortage of vaccines, the Food and Drug Administration announced it is ...

The US government is considering a change to how physicians give monkeypox vaccines so it can make the most of the supply on hand, US Food and Drug Administration Commissioner Dr. Robert Califf said ...

LONDON, Aug 19 (Reuters) - European countries could stretch out limited supplies of the monkeypox vaccine by administering smaller doses of the shot, the European Medicines Agency (EMA) said on Friday ...

GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company that has developed and commercialized a needle-free platform to more effectively administer drugs and biologics, today announced they received an ...